Chimeric OspA genes, proteins and methods of use thereof
Patent
·
OSTI ID:1422826
The invention relates to the development of chimeric OspA molecules for use in a new Lyme vaccine. More specifically, the chimeric OspA molecules comprise the proximal portion from one OspA serotype, together with the distal portion from another OspA serotype, while retaining antigenic properties of both of the parent polypeptides. The chimeric OspA molecules are delivered alone or in combination to provide protection against a variety of Borrelia genospecies. The invention also provides methods for administering the chimeric OspA molecules to a subject in the prevention and treatment of Lyme disease or borreliosis.
- Research Organization:
- Research Foundation of the State University of New York, Amherst, NY; Brookhaven National Laboratory (BNL), Upton, NY (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- DE-SC0012704
- Assignee:
- Brookhaven Science Associates, LLC (Upton, NY)
- Patent Number(s):
- 9,895,434
- Application Number:
- 15/049,438
- OSTI ID:
- 1422826
- Resource Relation:
- Patent File Date: 2016 Feb 22
- Country of Publication:
- United States
- Language:
- English
Similar Records
Chimeric OspA genes, proteins and methods of use thereof
Recombinant constructs of Borrelia burgdorferi
A New Approach to a Lyme Disease Vaccine
Patent
·
Tue Apr 19 00:00:00 EDT 2022
·
OSTI ID:1422826
+3 more
Recombinant constructs of Borrelia burgdorferi
Patent
·
Tue Feb 20 00:00:00 EST 2007
·
OSTI ID:1422826
+1 more
A New Approach to a Lyme Disease Vaccine
Journal Article
·
Tue Feb 01 00:00:00 EST 2011
· Clinical Infectious Diseases
·
OSTI ID:1422826
+6 more